For hematological adverse events (AEs), the median time for neutropenia was 18.4 (0-77) days, and G-CSF injections were administered in 34 of 38 courses because the neutrophil count was less than 1.0×10exp9/L. The gene discussed is CSF3; the disease is neutropenia.